Market Research Logo

Stem Cell Therapy - Global Market Outlook (2015-2022)

Stem Cell Therapy - Global Market Outlook (2015-2022)

According to Stratistics MRC, the stem cell therapy market is expected to grow at a CAGR of 37.6% during the forecast period 2015 to 2022. Rising awareness about stem cell therapies is the key factor driving the market growth. Furthermore, rising prevalence of chronic diseases, increasing approvals of clinical trials for stem cells therapy, increasing funds from government and private organizations, technological advancements and rising focus towards human embryonic stem cells are some of the drivers fuelling the market growth. However, complications in preservation of stem cells and lack of required infrastructures are the restraints hampering the market growth. Evolution of new therapies and low regulatory frameworks in emerging regions are expected to provide opportunities for market growth over the forecast period.

North America is expected to account for the largest share of the global market over the forecast period due to advancements in stem cell therapy and continuous R & D activities on stem cells. Whereas, Asia Pacific is likely to witness highest growth on account of favourable government policies, increasing adoption of stem cell therapy and rising population in China and India.

Some of the key players in stem cell therapy market include Aastrom Biosciences Inc., Cellular Dynamics International Inc., ReNeuron Group plc, Roslin Cells limited, Advanced Cell Technologies Inc., Cytori Therapeutics Inc., Celgene Corporation, Gamida Cell Ltd., International Stem Cell Corp., Mesoblast Ltd., Pluristem Therapeutics Inc., Fibrocell Science Inc., Stemcells Inc., Regeneus Ltd and Athersys Inc.

Treatments Covered:
Autologous stem cell therapy
CNS Diseases
Wounds and Injuries
CVS Diseases
Musculoskeletal Disorders
GIT Diseases
Other Diseases
Allogeneic stem cell therapy
CNS Diseases
Musculoskeletal Disorders
Wounds and Injuries
GIT diseases
Metabolic Diseases
Immune System Diseases
Eye Diseases
CVS Diseases
Other Diseases

End Users Covered:
Hospitals
Ambulatory Surgical Centers

Applications Covered:
Cardiovascular diseases
Eye diseases
Metabolic diseases
Musculoskeletal disorders
Gastro intestine diseases
Central Nervous System diseases
Immune system diseases
Wounds and injuries
Other diseases

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancement


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Application Analysis
3.8 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Stem Cell Therapy Market, By Treatment
5.1 Introduction
5.2 Autologous stem cell therapy
5.2.1 CNS Diseases
5.2.2 Wounds and Injuries
5.2.3 CVS Diseases
5.2.4 Musculoskeletal Disorders
5.2.5 GIT Diseases
5.2.6 Other Diseases
5.3 Allogeneic stem cell therapy
5.3.1 CNS Diseases
5.3.2 Musculoskeletal Disorders
5.3.3 Wounds and Injuries
5.3.4 GIT diseases
5.3.5 Metabolic Diseases
5.3.6 Immune System Diseases
5.3.7 Eye Diseases
5.3.8 CVS Diseases
5.3.9 Other Diseases
6 Global Stem Cell Therapy Market, By End User
6.1 Introduction
6.2 Hospitals
6.3 Ambulatory Surgical centers
7 Global Stem Cell Therapy Market, By Application
7.1 Introduction
7.2 Cardiovascular diseases
7.3 Eye diseases
7.4 Metabolic diseases
7.5 Musculoskeletal disorders
7.6 Gastro intestine diseases
7.7 Central Nervous System diseases
7.8 Immune system diseases
7.9 Wounds and injuries
8.10 Other diseases
8 Global Stem Cell Therapy Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Aastrom Biosciences Inc.
10.2 Cellular Dynamics International Inc.
10.3 ReNeuron Group plc
10.4 Roslin Cells limited
10.5 Advanced Cell Technologies Inc.
10.6 Cytori Therapeutics Inc.
10.7 Celgene Corporation
10.8 Gamida Cell Ltd.
10.9 International Stem Cell Corporation
10.10 Mesoblast Ltd.
10.11 Pluristem Therapeutics Inc.
10.12 Fibrocell Science Inc.
10.13 Stemcells Inc.
10.14 Regeneus Ltd
10.15 Athersys Inc.
List of Tables
Table 1 Global Stem Cell Therapy Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
Table 3 Global Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
Table 4 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 5 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 6 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 7 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 8 Global Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
Table 9 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 10 Global Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
Table 11 Global Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 12 Global Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 13 Global Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 14 Global Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
Table 15 Global Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
Table 16 Global Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
Table 17 Global Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
Table 18 Global Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 19 Global Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 20 Global Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
Table 21 Global Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
Table 22 Global Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
Table 23 Global Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
Table 24 Global Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
Table 25 Global Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
Table 26 Global Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
Table 27 Global Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
Table 28 Global Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
Table 29 Global Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
Table 30 Global Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
Table 31 Global Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
Table 32 Global Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
Table 33 Global Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
Table 34 North America Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
Table 35 North America Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
Table 36 North America Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
Table 37 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 38 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 39 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 40 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 41 North America Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
Table 42 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 43 North America Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
Table 44 North America Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 45 North America Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 46 North America Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 47 North America Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
Table 48 North America Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
Table 49 North America Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
Table 50 North America Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
Table 51 North America Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 52 North America Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 53 North America Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
Table 54 North America Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
Table 55 North America Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
Table 56 North America Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
Table 57 North America Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
Table 58 North America Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
Table 59 North America Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
Table 60 North America Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
Table 61 North America Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
Table 62 North America Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
Table 63 North America Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
Table 64 North America Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
Table 65 North America Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
Table 66 North America Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
Table 67 Europe Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
Table 68 Europe Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
Table 69 Europe Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
Table 70 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 71 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 72 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 73 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 74 Europe Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
Table 75 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 76 Europe Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
Table 77 Europe Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 78 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 79 Europe Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 80 Europe Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
Table 81 Europe Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
Table 82 Europe Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
Table 83 Europe Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
Table 84 Europe Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 85 Europe Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 86 Europe Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
Table 87 Europe Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
Table 88 Europe Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
Table 89 Europe Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
Table 90 Europe Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
Table 91 Europe Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
Table 92 Europe Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
Table 93 Europe Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
Table 94 Europe Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
Table 95 Europe Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
Table 96 Europe Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
Table 97 Europe Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
Table 98 Europe Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
Table 99 Europe Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
Table 100 Asia Pacific Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
Table 101 Asia Pacific Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
Table 102 Asia Pacific Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
Table 103 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 104 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 105 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 106 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 107 Asia Pacific Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
Table 108 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 109 Asia Pacific Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
Table 110 Asia Pacific Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 111 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 112 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 113 Asia Pacific Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
Table 114 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
Table 115 Asia Pacific Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
Table 116 Asia Pacific Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
Table 117 Asia Pacific Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 118 Asia Pacific Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 119 Asia Pacific Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
Table 120 Asia Pacific Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
Table 121 Asia Pacific Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
Table 122 Asia Pacific Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
Table 123 Asia Pacific Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
Table 124 Asia Pacific Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
Table 125 Asia Pacific Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
Table 126 Asia Pacific Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
Table 127 Asia Pacific Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
Table 128 Asia Pacific Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
Table 129 Asia Pacific Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
Table 130 Asia Pacific Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
Table 131 Asia Pacific Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
Table 132 Asia Pacific Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)
Table 133 RoW Stem Cell Therapy Market Outlook, By Country (2013-2022) ($MN)
Table 134 RoW Stem Cell Therapy Market Outlook, By Treatment (2013-2022) ($MN)
Table 135 RoW Stem Cell Therapy Market Outlook, By Autologous stem cell therapy (2013-2022) ($MN)
Table 136 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 137 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 138 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 139 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 140 RoW Stem Cell Therapy Market Outlook, By GIT Diseases (2013-2022) ($MN)
Table 141 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 142 RoW Stem Cell Therapy Market Outlook, By Allogeneic stem cell therapy (2013-2022) ($MN)
Table 143 RoW Stem Cell Therapy Market Outlook, By CNS Diseases (2013-2022) ($MN)
Table 144 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal Disorders (2013-2022) ($MN)
Table 145 RoW Stem Cell Therapy Market Outlook, By Wounds and Injuries (2013-2022) ($MN)
Table 146 RoW Stem Cell Therapy Market Outlook, By GIT diseases (2013-2022) ($MN)
Table 147 RoW Stem Cell Therapy Market Outlook, By Metabolic Diseases (2013-2022) ($MN)
Table 148 RoW Stem Cell Therapy Market Outlook, By Immune System Diseases (2013-2022) ($MN)
Table 149 RoW Stem Cell Therapy Market Outlook, By Eye Diseases (2013-2022) ($MN)
Table 150 RoW Stem Cell Therapy Market Outlook, By CVS Diseases (2013-2022) ($MN)
Table 151 RoW Stem Cell Therapy Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 152 RoW Stem Cell Therapy Market Outlook, By End User (2013-2022) ($MN)
Table 153 RoW Stem Cell Therapy Market Outlook, By Hospitals (2013-2022) ($MN)
Table 154 RoW Stem Cell Therapy Market Outlook, By Ambulatory Surgical centers (2013-2022) ($MN)
Table 155 RoW Stem Cell Therapy Market Outlook, By Application (2013-2022) ($MN)
Table 156 RoW Stem Cell Therapy Market Outlook, By Introduction (2013-2022) ($MN)
Table 157 RoW Stem Cell Therapy Market Outlook, By Cardiovascular diseases (2013-2022) ($MN)
Table 158 RoW Stem Cell Therapy Market Outlook, By Eye diseases (2013-2022) ($MN)
Table 159 RoW Stem Cell Therapy Market Outlook, By Metabolic diseases (2013-2022) ($MN)
Table 160 RoW Stem Cell Therapy Market Outlook, By Musculoskeletal disorders (2013-2022) ($MN)
Table 161 RoW Stem Cell Therapy Market Outlook, By Gastro intestine diseases (2013-2022) ($MN)
Table 162 RoW Stem Cell Therapy Market Outlook, By Central Nervous System diseases (2013-2022) ($MN)
Table 163 RoW Stem Cell Therapy Market Outlook, By Immune system diseases (2013-2022) ($MN)
Table 164 RoW Stem Cell Therapy Market Outlook, By Wounds and injuries (2013-2022) ($MN)
Table 165 RoW Stem Cell Therapy Market Outlook, By Other diseases (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report